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Commentary
The U.S. Environmental Protection Agency 
(EPA) and other regulatory agencies are respon-
sible for managing large numbers of environ-
mental chemicals. Although current regulatory 
decisions are based on a wide range of tools and 
information that represent the best available 
science, often limited or no exposure or toxic-
ity data are available for making these decisions 
(Judson et al. 2009). Recent statutory changes 
require increasingly complex approaches for 
evaluating the impact of life-stage vulnerabil-
ity, genetic susceptibility, varying exposure sce-
narios, and exposures to multiple stressors on 
environmental health risks. These new require-
ments push the limits of our current tools and 
scientific understanding. Fortunately, the rapid 
explosion of new computational, physical, and 
biological science tools have the potential to 
address these challenges and to transform the 
ways in which exposure and toxicity testing 
come together to assess health risks. 
Because of the number of chemicals 
involved and the increasing complexity 
of future assessments, new approaches are 
needed. To examine and address these limita-
tions, the National Research Council (NRC) 
evaluated the issues and developed a frame-
work for toxicity testing as it could be applied 
to risk assessment. The report, Toxicity Testing 
in the 21st Century: A Vision and Strategy 
(NRC 2007), articulates a long-range vision 
that applies systems biology, rapid assay tech-
nologies, and bioinformatic tools to improve 
toxicity testing. Although the focus was 
intentionally on toxicity testing, the NRC 
recognized that exposure must be a key com-
ponent if the intended goal is to evaluate risks 
and inform public health decisions. Exposure 
science, when incorporated throughout the 
entire framework, will increase the efficiency 
of the testing process, help inform toxicity 
testing, describe risks, and verify the out-
comes of new risk assessment approaches. The 
NRC recommended that exposure science be 
considered at every step in the new testing 
and risk assessment strategy.
In this commentary, we establish a stra-
tegic framework for the exposure research 
needed to achieve a new approach for risk 
assessment. Crucial to this vision is the appli-
cation of a systems approach that fully inte-
grates exposure and toxicity information in 
a holistic framework for improved public 
health decision making. We also elaborate on 
the exposure research needed to achieve this 
new vision. 
A Systems Approach for 
Assessing Risk
The authors of Toxicity Testing in the 21st 
Century (NRC 2007) proposed to use sys-
tems biology to serve as the basis for a new 
toxicity-testing paradigm. The fundamen-
tal construct is to develop in vitro tests to 
characterize toxicity pathway perturbations 
and then predict health impacts that could 
result from these perturbations. If we broaden 
this vision, systems theory also provides the 
required conceptual framework for linking 
exposure science and toxicology in order to 
study, characterize, and predict the complex 
interactions between humans and environ-
mental chemicals that lead to health risks. 
Toxicity pathways, as articulated by the 
NRC, are normal pathways for maintain-
ing cellular functions that, when sufficiently 
perturbed, will lead to an adverse health out-
come. The consequences of a perturbation 
depend on its magnitude, which is related to 
dose at the cellular level, the timing and dura-
tion of the perturbation, and the susceptibility 
and life stage of the host. Exposure science 
provides information on the magnitude, tim-
ing, and duration of individual exposure as 
well as the resulting dose at the tissue, cellu  lar, 
and even molecular level (Cohen Hubal et al. 
2008). Importantly, exposure information will 
determine whether toxicity pathways can be 
perturbed and whether there is a risk.
A fully integrated systems approach will 
reduce many of the uncertainties with current 
risk assessment approaches. Understanding 
the mechanisms of toxicity pathways will 
reduce uncertainties associated with using 
animal data to predict human risk. When 
integrated with exposure and dose informa-
tion, it also affords the opportunity to reduce 
uncertainties associated with using high doses 
to predict risk at lower environmental expo-
sures, predict cumulative risks, and predict 
risk to susceptible populations.
Exposure Science for the 
21st Century
Because of the complex nature of the human 
system, health risk predictions associated with 
chemical exposures will be only as good as the 
least resolved or least understood component. 
Advanced tools are available to rapidly exam-
ine toxicity pathways at a depth and breadth 
not previously possible. For a fully integrated 
system, a comparable set of advanced exposure 
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tools must be developed; these tools must be 
rapid, efficient, and predictive. 
Exposure science provides the linkages 
between what is present in the environment 
and the internal dose that individuals and 
populations receive. A strategic long-term 
program for exposure research must develop 
predictive computation tools based on a 
mechanistic understanding of important (i.e., 
rate-limiting) exposure processes and determi-
nants. High-priority research needs include 
the development and application of
•	integrated	modeling	approaches	to	reliably	
predict exposure and dose
•	highly	efficient	screening	tools	for	chemical	
prioritization
•	easily	accessible	exposure	databases	aligned	
with toxicity databases
•	efficient	and	affordable	tools	for	generating	
new exposure and dose data.
Integrated modeling approaches for pre-
dicting exposure and dose. Computational 
models that can be efficiently integrated to 
predict exposure and dose at the toxicity path-
way are fundamental to the new risk assess-
ment vision. These models, in turn, should be 
integrated with dose‒response and biological 
pathways models to describe the entire source 
to outcome continuum. 
Exposure models estimate concentrations of 
chemicals in environmental media and describe 
activities that bring individuals into contact 
with the contaminated media. Several mod-
els have been developed and applied for this 
purpose (Williams et al., in press). The U.S. 
EPA Stochastic Human Exposure and Dose 
Simulation (SHEDS) model (U.S. EPA 2009a) 
can track activities minute by minute through-
out the day and link these activities to environ-
mental concentrations to estimate exposures 
by specific route and pathways (Zartarian et al. 
2006). The longitudinal aspect of the model 
provides the ability to estimate not only the 
magnitude, but also the frequency and dura-
tion of exposure over the same time period. 
When SHEDS model outputs are linked to a 
physiologically based pharmacokinetic (PBPK) 
model such as U.S. EPA’s Exposure Related 
Dose Estimating Model (ERDEM) (U.S. EPA 
2007; Zhang et al. 2007), the magnitude, fre-
quency, and duration of internal dose can also 
be predicted. Figure 1 illustrates this linkage 
for methyl tert-butyl ether exposures. 
Integrated exposure/PBPK models can 
be used in several ways. Outputs can be used 
directly to inform toxicity testing as well as to 
conduct quantitative risk assessments. Linked 
models can simulate dose for multiple routes 
(inhalation, ingestion, and dermal) and mul-
tiple chemicals simultaneously, thus provid-
ing the ability to evaluate cumulative risks. 
Integrated models also provide the ability to 
evaluate risks to susceptible populations by 
considering differential activities that could 
change exposures or differential physiology 
that could affect adsorption, distribution, 
metabolism, or elimination characteristics. 
Finally, the models can be used in reverse for 
dose reconstruction as an alternative approach 
for comparing toxicity testing results to popu-
lation exposures (Georgopoulos et al. 2008; 
Tan et al. 2007).
Realizing the potential for integrated 
modeling approaches requires a coordinated 
and sustained research effort. PBPK models 
need to be extended to allow dose estimation 
at the cellular and molecular level. Integrated 
exposure/PBPK models must be enhanced 
to provide distributional outputs along with 
uncertainty and variability. Developing sys-
tems that are efficient and generalizable must 
be a part of this effort. New data and new 
approaches are needed for exposure recon-
struction in order to reduce uncertainties 
with current approaches. Current efforts 
(Georgopoulos and Lioy 2006; Rosenbaum 
et al. 2007) to provide models that use a com-
mon platform and/or common programming 
language must continue. 
At the same time, research is required 
to develop approaches for estimating model 
inputs and parameters without resource-inten-
sive and burdensome studies. For example, 
environmental informatics, quantitative struc-
ture–activity relationships (QSARs), and com-
putational chemistry approaches should be 
developed to predict and quantify behaviors 
such as environmental fate and transport or 
metabolism. Development of metabolic pre-
dictors or simulators that can address single 
chemicals, multiple chemicals, and the inter-
action among chemicals should be accelerated 
(Mekenyan et al. 2005). Novel statistical and 
informatic approaches should be applied to 
extant exposure data to facilitate the identifica-
tion of critical metrics that represent personal 
exposure through time, place, life stage, life-
style, or behavior. 
Exposure screening tools for accelerated 
chemical prioritization. Current risk assess-
ment approaches cannot meet demands for 
the large number of chemicals that must be 
evaluated. Screening tools are needed that 
reliably identify those chemicals that will 
require more comprehensive risk assessments. 
Chemical prioritization should consider 
both exposure and hazard. The U.S. EPA, 
through its ToxCast program (U.S. EPA 
2009b),  is developing rapid in vitro assays to 
screen chemicals for further testing based on 
toxicity (Dix et al. 2007). Innovative rapid-
screening tools based on exposure are also 
needed. Predictive approaches for estimat-
ing important parameters for screening need 
to be developed. Ideally, these tools should 
account for chemical use, physical and chemi-
cal properties, occurrence and co-occurrence 
of chemicals, potential exposure scenarios, 
routes of exposure, and various exposure fac-
tors. This will include developing approaches 
that describe a chemical’s behavior in the 
environment as well as approaches to identify 
important human activities that will impact 
exposure. Exposure prioritization approaches 
will require easily accessible databases, as 
described below. Figure 1. Illustration of linked exposure (SHEDS) and dose (ERDEM) models for methyl tert-butyl ether. 
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One plausible approach may be to formu-
late an exposure classification index based on 
a limited set of metrics designed to efficiently 
cover exposure potential (Cohen Hubal et al. 
2008). As a first step, innovative approaches 
for chemical prioritization (e.g., Arnot and 
MacKay 2008; Hays et al. 2007) as well as 
indexing approaches from other fields should 
be reviewed and mined. This index could be 
“trained” on data-rich chemicals and products 
and then validated on a representative set of 
chemicals for which little exposure data are 
available. In this way, a limited set of criti-
cal metrics could be identified for efficient 
screening of new chemicals. Finally, because 
consumer products often incorporate mul-
tiple chemicals in a variety of forms, rapid 
experimental screening protocols that measure 
the potential for availability or release of these 
compounds into exposure media are under 
early development and should be pursued fur-
ther (Little and Cohen Hubal, in press). 
Significant research and model develop-
ment activities are currently under develop-
ment within the U.S. EPA (U.S. EPA 2005) 
as well as in Canada and Europe (Bridges 
2007; Environment Canada 1999; Van der 
Wielen 2007). Partnerships with these groups 
should be fostered to leverage and establish 
collaborative exposure science research for 
future chemical screening and prioritization.
Exposure databases. Easily accessible 
exposure databases that can be linked to each 
other and with toxicity databases can and 
should be developed immediately. Data on 
chemical manufacture, product use, environ-
mental fate, media concentrations, biomarker 
levels, and metabolism should be identified. 
International standards for exposure data rep-
resentation should be discussed. Approaches 
for improving access to human exposure data 
and for facilitating links between exposure 
and toxicity data should be implemented. 
Existing tools and platforms that are cur-
rently being implemented with environmen-
tal toxicity information should be adapted 
for exposure information to provide the most 
useful links to existing toxicity data. Chemical 
structure annotation of exposure-related data, 
such as could be provided by the Distributed 
Structure Searchable Toxicity (DSSTox) data-
base (Richard et al. 2006, 2008; U.S. EPA 
2009c), and incorporation of such data into 
the new Aggregate Computational Toxicology 
Resource (ACToR) (Judson et al. 2008) will 
greatly enhance linkages between these data 
and toxicity-related human health end points. 
For maximum impact, this activity should 
be conducted in collaboration with inter-
national partners working to achieve similar 
goals (Environment Canada 1999; Van der 
Wielen 2007). 
Efficient monitoring methods for assessing 
risk. Population-based and surveillance studies 
will provide the ability to link the results from 
toxicity testing to the real world and to track 
our progress in protecting public health. To be 
feasible, new low-cost, low-burden methods 
and approaches for conducting these studies 
will be needed. New technologies need to be 
applied to develop a toolbox of methods for 
assessing exposure, susceptibility, and biologi-
cal response in large surveillance studies. New 
sensor technologies, applications of nano-
technology, geographic information systems, 
and genomics assays need to be developed and 
put into use for this purpose. 
Emerging tools in molecular biology 
provide the potential to develop cellular and 
molecular indicators of exposure and bio-
logical response. Better understanding of 
genomic expression may also provide insight 
into factors impacting differences in suscep-
tibility to chemical exposure in the human 
population (Oberemm et al. 2005). “Omics” 
should be explored as a way to identify 
expression patterns associated with exposure 
to individual chemicals or chemical mixtures. 
Such technologies could then provide link-
ages between exposure and health outcomes 
in population studies. Development of envi-
ronmental and/or molecular indicators of 
exposure combined with development of 
novel sensor-based moni  toring tools will pres-
ent the opportunity for simultaneous, near-
real-time measure  ment of exposure and dose 
to multiple real-world stressors in mixtures 
(Weis et al. 2005). A strong and immedi-
ate research effort is required for novel tech-
nologies that will generate the data required 
for risk assessments and decisions that truly 
  protect public health. 
Conclusions
Exposure science is crucial for addressing many 
of our important and complex environmen-
tal health issues. As discussed here, exposure 
science is essential for toxicity testing to be 
valuable in public health protection. A systems 
approach is required that fully integrates expo-
sure and toxicity into a holistic framework for 
risk assessment. 
The exposure community must step up 
to the challenge to develop a robust and pre-
dictive science that can be used to address 
the complex problems in the 21st century. A 
research program that provides the necessary 
exposure data and tools within an integrated 
framework will need to be multidisciplinary 
and take advantage of collaborative opportuni-
ties. Key to this work are strong collaborations 
within the exposure community and with 
those researchers who are developing infor-
mation on toxicity pathways and conducting 
toxicity testing. Multiple collaborations are 
needed to ensure that
•	chemical	prioritization	considers	both	
  exposure and toxicity
•	databases	are	developed
•	analysis	is	conducted	using	these	databases	
to understand exposures, doses, and toxicity
•	new	information	on	biological	interactions	
and pathways is used to develop the appro-
priate indicators for exposure and surveillance 
studies
•	models	on	exposure	and	dose	are	linked	for	
extrapolations
•	feedback	loops	are	developed	to	inform	
future planned research.
Collaborations should include partnerships 
between governmental and nongovernmental 
research groups as well as academia and indus-
try for developing and applying new exposure 
tools. Just as a new vision and initiatives have 
been developed for toxicity testing, it is now 
time for the exposure community to dedicate 
itself to engaging in similar activities to move 
our science into the 21st century. 
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